Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis
Clinical trial NCT01177228 · COMPLETED
Trial details
- NCT number
- NCT01177228
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2008-06-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.